GEORGE YANCOPOULOS - 05 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
President and Chief Scientific, Director
Signature
/s/**George D. Yancopoulos
Issuer symbol
REGN
Transactions as of
05 Aug 2021
Transactions value $
$-30,003,000
Form type
4
Filing time
06 Aug 2021, 16:03:49 UTC
Previous filing
23 Jun 2021
Next filing
17 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $-30,003,000 -50,000 -5.06% $600.06 937,483 05 Aug 2021 Direct F1, F2
transaction REGN Common Stock Gift $0 +211,585 +10037% $0.000000 213,693 24 Jun 2021 By Trust for Chldn. F3
transaction REGN Common Stock Gift $0 -211,585 -100% $0.000000* 0 24 Jun 2021 by 2019 GRAT
holding REGN Common Stock 5,848 05 Aug 2021 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 50,000 shares of Company stock on August 5, 2021 at prices ranging from $600.00 to $600.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2021 at each separate price.
F3 As investment trustee of trusts for the benefit of the reporting person's children.